1784.TWO Bionet

Healthcare Biotechnology Taiwan OTC Exchange
45.90 TWD
Close of Nov 6, 2026
43.05 118.00
Market cap
TWD 2.38B
P/E
40.6x
P/B
2.02x
ROE
5.2%
Dividend yield
2.94%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 1784.TWO undervalued?

Graham number
Price45.90
Graham value24.02
Premium91.1%

1784.TWO trades 91.1% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Bionet fundamental analysis

No fundamental analysis for Bionet yet.

Bionet stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Bionet

BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem ce…

Full company profile